Exopharm (ASX:EX1) Share Price and News - StockTrack

Market Cap (3-Jun) $27,342,400 (1,032nd)	Close (30-Jun) $0.008 0 (0%)	Volume (30-Jun) 285,280	Shortsold (12-Dec) 6,497 (0.00%) (681st)
52w High $0.000	52w Low $0.000	P/E -	EPS -0.09

	Subject
	EX1 EX1 Ann: Investor Webinar Presentation
	1 (current) 2 3
	EX1 EX1 Ann: Notification regarding unquoted securities - EX1
	EX1 EX1 Ann: Quarterly Activities Report and Appendix 4C
	EX1 EX1 Ann: Update - Partnering & Licensing Focus Continues
	EX1 EX1 Ann: Investor Presentation
	EX1 EX1 Ann: Exopharm LEAP Exosome Technology Granted 1st National Patent
	EX1 EX1 Ann: Appendix 2A
	EX1 EX1 Ann: Change in substantial holding - ID
	EX1 EX1 Ann: Cleansing Notice
	EX1 EX1 Ann: Appendix 2A
	EX1 EX1 Ann: Proposed issue of Securities - EX1
	EX1 EX1 Ann: Exopharm Receives Firm Commitments to Raise $12 million
	EX1 EX1 Ann: Investor Presentation - Delivering Transformative Medicines
	EX1 EX1 Ann: Quarterly Activities Report and Appendix 4C
	EX1 EX1 Ann: Trading Halt
	EX1 EX1 Ann: Exopharm Shareholder Update - Revenue Focus in 2021
	EX1 EX1 Ann: Appendix 3G
	EX1 EX1 Ann: LEAP Technology- Advanced EV Medicines from Blood Components
	EX1 EX1 Ann: Positive PLEXOVAL II Phase 1 Clinical Trial Results
	EX1 EX1 Ann: Securities Trading Policy
	EX1 EX1 Ann: Preclinical Data from Osteoarthritis Animal Study
	EX1 EX1 Ann: Appendix 4D and Half Year Financial Report
	EX1 EX1 Ann: Securities Trading Policy
	EX1 EX1 Ann: Exopharm presents at Bio CEO & Investor Digital Conference
	EX1 EX1 Ann: Change of Director's Interest Notices - JW and ID
	EX1 EX1 Ann: Substantial Shareholder notices - amendment
	EX1 EX1 Ann: Response to ASX Price and Volume Query
	EX1 EX1 Ann: Quarterly Report and Appendix 4C
	EX1 EX1 Ann: Progress Points To Partnering Readiness
	EX1 EX1 Ann: Initial Director's Interest Notice - EM
	EX1 EX1 Ann: Final Director's Interest Notice - DP
	EX1 EX1 Ann: Exopharm Board Changes
	EX1 EX1 Ann: Change in substantial holding
	EX1 EX1 Ann: Becoming a substantial holder
	EX1 EX1 Ann: Lapse of Performance Rights
	EX1 EX1 Ann: Response to ASX Price and Volume Query
	EX1 EX1 Ann: Change of Director's Interest Notice
	EX1 EX1 Ann: Shareholder Update
	EX1 EX1 Ann: Appendix 2A
	EX1 EX1 Ann: Release of Securities from 24 Month Escrow
	EX1 EX1 Ann: Change of Director's Interest Notice
	EX1 EX1 Ann: Cleansing Notice
	EX1 EX1 Ann: Appendix 2A
	EX1 EX1 Ann: Results of Meeting
	EX1 EX1 Ann: Change of Registered Office Address
	EX1 EX1 Ann: Updated Quarterly Activities Report
	EX1 EX1 Ann: Exopharm to Present at Key Exosome Industry Event
	EX1 EX1 Ann: Change in substantial holding
	EX1 EX1 Ann: Change of Director's Interest Notice
	EX1 EX1 Ann: Change of Director's Interest Notice

Similar Companies

CSL

Clinuvel Pharmaceuticals

CUV

Immutep

IMM

Imugene

IMU

Mesoblast

MSB

Opthea

OPT

Paradigm Biopharmaceuticals

PAR

PYC Therapeutics

PYC

Race Oncology

RAC

Telix Pharmaceuticals

TLX

End of Day Prices

Date	Close	Volume	Change
31-May	$0.02	3,375,302	0.00 (16.36%)
10-May	$0.03	0	0.00 (0.00%)
09-May	$0.03	0	0.00 (0.00%)
08-May	$0.03	0	0.00 (0.00%)
07-May	$0.03	0	0.00 (0.00%)
06-May	$0.03	0	0.00 (0.00%)
03-May	$0.03	0	0.00 (0.00%)
02-May	$0.03	0	0.00 (0.00%)
01-May	$0.03	0	0.00 (0.00%)
30-Apr	$0.03	0	0.00 (0.00%)
29-Apr	$0.03	0	0.00 (0.00%)
26-Apr	$0.03	0	0.00 (0.00%)
24-Apr	$0.03	0	0.00 (0.00%)
23-Apr	$0.03	0	0.00 (0.00%)
22-Apr	$0.03	0	0.00 (0.00%)
0 up, 1 down, and 14 flat days

High $0.01	Low $0.01	Trades 7	Turnover $2,282	Volume 285,280
30 June 2023 at 3:59pm

High $0.01	Low $0.01	Trades 7	Turnover $2,282	Volume 285,280
30 June 2023 at 3:59pm

Exopharm Health Care

$0.008 (0%)

$0.008 (0%)

Followers

Prices

Announcements

Similar Companies

End of Day Prices